Filing Flows › Century Therapeutics (IPSC) › Recalls, complaints & regulation
Century Therapeutics (IPSC): clinical trials
Century Therapeutics (IPSC) beyond its filings: 2 active clinical trials.
Century Therapeutics' latest quarter
Century Therapeutics, Q1 2025: revenue $109M (128× year over year), operating margin 67.9%, net earnings $76.6M, operating cash flow −$34.6M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Century Therapeutics have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.